These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16934383)

  • 41. Misoprostol: an old drug, new indications.
    More B
    J Postgrad Med; 2002; 48(4):336-9. PubMed ID: 12571404
    [No Abstract]   [Full Text] [Related]  

  • 42. Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial.
    Cheng SY; Ming H; Lee JC
    Obstet Gynecol; 2008 Jan; 111(1):119-25. PubMed ID: 18165400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subgroup analysis and statistical power.
    Martins WP; Zanardi JV
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):244; author reply 245. PubMed ID: 21840112
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy and safety of six hourly vaginal misoprostol versus intracervical dinoprostone: a randomized controlled trial.
    Denguezli W; Trimech A; Haddad A; Hajjaji A; Saidani Z; Faleh R; Sakouhi M
    Arch Gynecol Obstet; 2007 Aug; 276(2):119-24. PubMed ID: 17219155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor.
    Mahajan NN; Mahajan K; Soni R
    Gynecol Obstet Invest; 2007; 64(2):82; author reply 83. PubMed ID: 17308389
    [No Abstract]   [Full Text] [Related]  

  • 46. A comparison between single dose of 50 microg oral misoprostol and 25 microg vaginal misoprostol for labor induction.
    Paisarntantiwong R; Getgan M
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S56-62. PubMed ID: 17722318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Misoprostol vaginal insert compared with dinoprostone vaginal insert: a randomized controlled trial.
    Wing DA;
    Obstet Gynecol; 2008 Oct; 112(4):801-12. PubMed ID: 18827122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Balloon catheter vs. cervical vacuum cup for hysterosalpingography: a prospective, randomized, single-blinded study.
    Ricci G; Guastalla P
    Fertil Steril; 2009 Jan; 91(1):299-300. PubMed ID: 19062006
    [No Abstract]   [Full Text] [Related]  

  • 49. Success rates with low dose misoprostol before induction of labor for nulliparas with severe preeclampsia at various gestational ages.
    Berkley E; Meng C; Rayburn WF
    J Matern Fetal Neonatal Med; 2007 Nov; 20(11):825-31. PubMed ID: 17943644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ACOG Committee Opinion No. 427: Misoprostol for postabortion care.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2009 Feb; 113(2 Pt 1):465-8. PubMed ID: 19155922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of labour in nulliparous and multiparous women: a UK, multicentre, open-label study of intravaginal misoprostol in comparison with dinoprostone.
    Calder AA; Loughney AD; Weir CJ; Barber JW
    BJOG; 2008 Sep; 115(10):1279-88. PubMed ID: 18715414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized trial of preinduction cervical ripening: misoprostol vs oxytocin.
    Fonseca L; Wood HC; Lucas MJ; Ramin SM; Phatak D; Gilstrap LC; Yeomans ER
    Am J Obstet Gynecol; 2008 Sep; 199(3):305.e1-5. PubMed ID: 18771993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic profiles of controlled-release hydrogel polymer vaginal inserts containing misoprostol.
    Powers BL; Wing DA; Carr D; Ewert K; Di Spirito M
    J Clin Pharmacol; 2008 Jan; 48(1):26-34. PubMed ID: 18071191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hysterosalpingography in a case of extensive damage of the external os and marked dilatation of the cervical canal].
    Radowicki S; Mlosek K
    Ginekol Pol; 1985 Feb; 56(2):69-72. PubMed ID: 4043790
    [No Abstract]   [Full Text] [Related]  

  • 55. A randomised comparison of patient satisfaction with vaginal and sublingual misoprostol for induction of labour at term.
    Nassar AH; Awwad J; Khalil AM; Abu-Musa A; Mehio G; Usta IM
    BJOG; 2007 Oct; 114(10):1215-21. PubMed ID: 17877674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design.
    Oppegaard KS; Nesheim BI; Istre O; Qvigstad E
    BJOG; 2007 Jun; 114(6):769, e1-12. PubMed ID: 17516971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness and safety of vaginal misoprostol for induction of labour in unfavourable cervix in 3rd trimester.
    Abbasi N; Danish N; Shakoor F; Parveen Z; Bilal SA
    J Ayub Med Coll Abbottabad; 2008; 20(3):33-5. PubMed ID: 19610511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors predicting failure of labour induction.
    Oboro VO; Isawumi AI; Akinola SE; Komolafe JO; Tijani AM; Adesina AO
    Niger Postgrad Med J; 2007 Jun; 14(2):137-9. PubMed ID: 17599113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early postpartum hemorrhage after induction of labor.
    Schott K; Anderson J
    J Midwifery Womens Health; 2008; 53(5):461-6. PubMed ID: 18761300
    [No Abstract]   [Full Text] [Related]  

  • 60. Factors affecting decidual IGFBP-1 levels in the vagina and cervix in the first and mid-second trimester of pregnancy.
    Rahkonen L; Unkila-Kallio L; Rutanen EM; Paavonen J
    BJOG; 2009 Jan; 116(1):45-54. PubMed ID: 19016684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.